{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:09:49Z","timestamp":1785510589228,"version":"3.56.0"},"reference-count":77,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Evidence indicates shared physiopathological mechanisms between autism and psychosis. In this regard, the endocannabinoid system has been suggested to modulate neural circuits during the early stage of neurodevelopment, with implications for both autism and psychosis. Nevertheless, such potential common markers of disease have been investigated in both autism and psychosis spectrum disorders, without considering the conundrum of differentiating the two groups of conditions in terms of diagnosis and treatment. Here, we systematically review all human and animal studies examining the endocannabinoid system and its biobehavioral correlates in the association between autism and psychosis. Studies indicate overlapping biobehavioral aberrancies between autism and schizophrenia, subject to correction by modulation of the endocannabinoid system. In addition, common cannabinoid-based pharmacological strategies have been identified, exerting epigenetic effects across genes controlling neural mechanisms shared between autism and schizophrenia. Interestingly, a developmental and transgenerational trajectory between autism and schizophrenia is supported by evidence that exogenous alteration of the endocannabinoid system promotes progression to inheritable psychosis phenotypes in the context of biobehavioral autism vulnerability. However, evidence for a diametral association between autism and psychosis is scant. Several clinical implications follow from evidence of a developmental continuum between autism and psychosis as a function of the endocannabinoid system dysregulation.<\/jats:p>","DOI":"10.3390\/ijerph19095616","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T13:10:26Z","timestamp":1651756226000},"page":"5616","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Autism\u2013Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-1920","authenticated-orcid":false,"given":"Marco","family":"Colizzi","sequence":"first","affiliation":[{"name":"Unit of Psychiatry, Department of Medicine (DAME), University of Udine, 33100 Udine, Italy"},{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bortoletto","sequence":"additional","affiliation":[{"name":"Child and Adolescent Neuropsychiatry Unit, Maternal-Child Integrated Care Department, Integrated University Hospital of Verona, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Costa","sequence":"additional","affiliation":[{"name":"Community Mental Health Team, Friuli Centrale University Health Service (ASUFC), 33057 Palmanova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-8025","authenticated-orcid":false,"given":"Sagnik","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Balestrieri","sequence":"additional","affiliation":[{"name":"Unit of Psychiatry, Department of Medicine (DAME), University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, (DSM-5), American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mercier, C. (1890). Sanity and Insanity, Walter Scott Publishing, Co.","DOI":"10.1037\/12978-000"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0010-440X(69)90002-9","article-title":"Disorders of perception common to early infantile autism and schizophrenia","volume":"10","author":"Ornitz","year":"1969","journal-title":"Compr Psychiatry"},{"key":"ref_4","unstructured":"Bleuler, E. (1911). Dementia Praecox oder Grupper der Schizophrenien, Deuticke."},{"key":"ref_5","unstructured":"American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders, (DSM-III), American Psychiatric Association. [3rd ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2010.11.031","article-title":"Is schizophrenia on the autism spectrum?","volume":"1380","author":"King","year":"2011","journal-title":"Brain Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-clinpsy-050212-185627","article-title":"Revisiting the relationship between autism and schizophrenia: Toward an integrated neurobiology","volume":"9","author":"King","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.31887\/DCNS.2020.22.1\/macrocq","article-title":"Neurodevelopmental disorders-the history and future of a diagnostic concept","volume":"22","author":"Crocq","year":"2020","journal-title":"Dialogues in Clin. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13033-020-00356-9","article-title":"Prevention and early intervention in youth mental health: Is it time for a multidisciplinary and trans-diagnostic model for care?","volume":"14","author":"Colizzi","year":"2020","journal-title":"Int. J. Ment. Health Syst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wps.20440","article-title":"Schizophrenia and the neurodevelopmental continuum:evidence from genomics","volume":"16","author":"Owen","year":"2017","journal-title":"World Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"662093","DOI":"10.3389\/fpsyt.2021.662093","article-title":"Neurodevelopmental Trajectories and Clinical Profiles in a Sample of Children and Adolescents With Early- and Very-Early-Onset Schizophrenia","volume":"12","author":"Pontillo","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11920-013-0409-9","article-title":"Defining psychosis: The evolution of DSM-5 schizophrenia spectrum disorders","volume":"15","author":"Bhati","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mp.2013.127","article-title":"Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders","volume":"19","author":"Kenny","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature13772","article-title":"Synaptic, transcriptional and chromatin genes disrupted in autism","volume":"515","author":"He","year":"2014","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12929","article-title":"De novo mutations in schizophrenia implicate synaptic networks","volume":"506","author":"Fromer","year":"2014","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/138955709787847921","article-title":"Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration","volume":"9","author":"Basavarajappa","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_17","first-page":"294","article-title":"Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An Introduction to the Endogenous Cannabinoid System","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1098\/rstb.2011.0385","article-title":"Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development","volume":"367","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00406-009-0028-y","article-title":"The endocannabinoid system and the regulation of neural development: Potential implications in psychiatric disorders","volume":"259","author":"Palazuelos","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.mce.2008.01.002","article-title":"Aspects of endocannabinoid signaling in periimplantation biology","volume":"286","author":"Sun","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.conb.2013.12.006","article-title":"Endogenous cannabinoid signaling at inhibitory interneurons","volume":"26","author":"Younts","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biocel.2013.12.007","article-title":"Endocannabinoid signalling in neuronal migration","volume":"47","author":"Zhou","year":"2014","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1515\/revneuro-2020-0134","article-title":"Endocannabinoid system in the neurodevelopment of GABAergic interneurons: Implications for neurological and psychiatric disorders","volume":"32","author":"Song","year":"2021","journal-title":"Rev. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157015911795017047","article-title":"Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders","volume":"9","author":"Onaivi","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cell.2015.06.056","article-title":"\u03b2-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling","volume":"162","author":"Anderson","year":"2015","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbi.2016.07.152","article-title":"Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling","volume":"58","author":"Doenni","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/15592294.2019.1656158","article-title":"Cannabis use is associated with potentially heritable widespread changes in autism candidate gene","volume":"15","author":"Schrott","year":"2020","journal-title":"Epigenetics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/s41598-020-72783-0","article-title":"Sperm DNA methylation altered by THC and nicotine: Vulnerability of neurodevelopmental genes with bivalent chromatin","volume":"10","author":"Schrott","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/em.22396","article-title":"Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus","volume":"61","author":"Wanner","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e769","DOI":"10.1038\/tp.2016.36","article-title":"Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium","volume":"6","author":"Stringer","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems\u2014A Retrospective Feasibility Study","volume":"49","author":"Aran","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41398-018-0137-3","article-title":"THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders","volume":"8","author":"Guennewig","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/jamapsychiatry.2019.2508","article-title":"Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits","volume":"76","author":"Legge","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Al-Soleiti, M., Balaj, K., Thom, R.P., McDougle, C.J., and Keary, C.J. (2021). Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder. J. Autism Dev. Disord.","DOI":"10.1007\/s10803-021-05254-8"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Powell, S.K., O\u2019Shea, C., Townsley, K., Prytkova, I., Dobrindt, K., Elahi, R., Iskhakova, M., Lambert, T., Valada, A., and Liao, W. (2021). Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk. Mol. Psychiatry.","DOI":"10.1101\/2021.04.01.438094"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13311-015-0371-9","article-title":"Endocannabinoid Signaling in Autism","volume":"12","author":"Chakrabarti","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamapsychiatry.2019.0970","article-title":"Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis","volume":"76","author":"Minichino","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: A proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Mol. Autism"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881119858306","article-title":"The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)","volume":"33","author":"Pretzsch","year":"2019","journal-title":"J. Psychopharmacol"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2016.07.068","article-title":"Effects of cannabidiol treatment on cortisol response to social stress in subjects at high risk of developing psychosis","volume":"71","author":"Mondelli","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"ref_42","first-page":"596","article-title":"Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis","volume":"51","author":"Wilson","year":"2020","journal-title":"Psychol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1192\/bjp.bp.116.187682","article-title":"Psychosis in autism: Comparison of the features of both conditions in a dually affected cohort","volume":"210","author":"Larson","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/schbul\/sbv032","article-title":"Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis","volume":"41","author":"Colizzi","year":"2015","journal-title":"Schizophr. Bull."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.psychres.2018.08.005","article-title":"Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort","volume":"268","author":"Colizzi","year":"2018","journal-title":"Psychiatry Res."},{"key":"ref_46","first-page":"60","article-title":"Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis","volume":"1","author":"Ranganathan","year":"2016","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.euroneuro.2018.04.003","article-title":"Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure","volume":"28","author":"Colizzi","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1037\/pha0000221","article-title":"Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing","volume":"26","author":"Colizzi","year":"2018","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Colizzi, M., Weltens, N., Lythgoe, D.J., Williams, S.C., Van Oudenhove, L., and Bhattacharyya, S. (2020). Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol. Psychol. Med.","DOI":"10.1017\/S0033291720003827"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Colizzi, M., Weltens, N., McGuire, P., Lythgoe, D., Williams, S., Van Oudenhove, L., and Bhattacharyya, S. (2019). Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: Implications for psychosis. Mol. Psychiatry.","DOI":"10.1038\/s41380-019-0374-8"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: Version III\u2014The final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Vi\u00f1als, X., Moreno, E., Lanfumey, L., Cordom\u00ed, A., Pastor, A., de La Torre, R., Gasperini, P., Navarro, G., Howell, L.A., and Pardo, L. (2015). Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002194"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01537552","article-title":"Serotonin and central nervous system syndromes of childhood: A review","volume":"3","author":"Coleman","year":"1973","journal-title":"J. Autism Child. Schizophr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"654246","DOI":"10.3389\/fpsyt.2021.654246","article-title":"Editorial: Neurobiology and Cognition Across the Autism-Psychosis Spectrum","volume":"12","author":"Sasson","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1054-3589(08)60849-2","article-title":"The modulation of corticoaccumbens transmission by limbic afferents and dopamine: A model for the pathophysiology of schizophrenia","volume":"42","author":"Grace","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41380-020-0648-1","article-title":"The importance of a developmental perspective in Psychiatry: What do recent genetic-epidemiological findings show?","volume":"25","author":"Thapar","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopsych.2017.09.020","article-title":"Developmental Changes Within the Genetic Architecture of Social Communication Behavior: A Multivariate Study of Genetic Variance in Unrelated Individuals","volume":"83","author":"Eaves","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/mp.2016.198","article-title":"ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties","volume":"23","author":"Robinson","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Blest-Hopley, G., Colizzi, M., Prata, D., Giampietro, V., Brammer, M., McGuire, P., and Bhattacharyya, S. (2021). Epigenetic Mediation of AKT1 rs1130233\u2019s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing. Brain Sci., 11.","DOI":"10.1101\/2021.06.30.450484"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0140525X08004214","article-title":"Psychosis and autism as diametrical disorders of the social brain","volume":"31","author":"Crespi","year":"2008","journal-title":"Behav Brain Sci"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3389\/fpsyg.2020.00833","article-title":"Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition","volume":"11","author":"Colizzi","year":"2020","journal-title":"Front. Psychol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Colizzi, M., Weltens, N., McGuire, P., Van Oudenhove, L., and Bhattacharyya, S. (2019). Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans. Brain Sci., 9.","DOI":"10.3390\/brainsci9040093"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s42003-021-02592-2","article-title":"Evidence of shared and distinct functional and structural brain signatures in schizophrenia and autism spectrum disorder","volume":"4","author":"Du","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/brain.2014.0324","article-title":"Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit\/Hyperactivity Disorder, and Tourette Syndrome","volume":"5","author":"Kern","year":"2015","journal-title":"Brain Connect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.110.084384","article-title":"Neurodevelopmental hypothesis of schizophrenia","volume":"198","author":"Owen","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2215-0366(16)30406-0","article-title":"Schizophrenia risk alleles and neurodevelopmental outcomes in childhood: A population-based cohort study","volume":"4","author":"Riglin","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1469-7610.2006.01614.x","article-title":"Continuities and discontinuities in psychopathology between childhood and adult life","volume":"47","author":"Rutter","year":"2006","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.bp.113.132324","article-title":"Psychopathology and cognition in children with 22q11.2 deletion syndrome","volume":"204","author":"Niarchou","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/aur.2004","article-title":"Autism spectrum disorder symptoms from ages 2 to 19 years: Implications for diagnosing adolescents and young adults","volume":"12","author":"Bal","year":"2019","journal-title":"Autism Res"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1007\/s10803-015-2520-8","article-title":"Psychiatric Symptoms in Youth with a History of Autism and Optimal Outcome","volume":"45","author":"Orinstein","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1192\/bjp.bp.110.080499","article-title":"Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys","volume":"197","author":"Kessler","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/ebmental-2018-300061","article-title":"Ultra-high-risk paradigm: Lessons learnt and new directions","volume":"21","author":"McGorry","year":"2018","journal-title":"Evid. Based Ment. Health"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/ebmental-2018-300060","article-title":"Early intervention in youth mental health: Progress and future directions","volume":"21","author":"McGorry","year":"2018","journal-title":"Evid. Based Ment. Health"},{"key":"ref_75","first-page":"80","article-title":"The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review","volume":"7","author":"Allen","year":"2009","journal-title":"JBI Libr. Syst. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1467-8624.2009.01380.x","article-title":"How the timing and quality of early experiences influence the development of brain architecture","volume":"81","author":"Fox","year":"2010","journal-title":"Child Dev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/070674370605100904","article-title":"What are the policy implications of the evidence on cannabis and psychosis?","volume":"51","author":"Hall","year":"2006","journal-title":"Can. J. Psychiatry"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/9\/5616\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:06:35Z","timestamp":1760137595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/9\/5616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijerph19095616"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19095616","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]}}}